All
Research
Education
Onderzoek
Onderwijs
Business
Oplossingen
EN
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
TR - Türkçe
JA - 日本語
PL - Polski
RU - Русский
HE - עִברִית
AR - العربية
Meld u aan
Department of Translational Science and Molecular Medicine
Christopher J. Kemp has not added Biography.
If you are Christopher J. Kemp and would like to personalize this page please email our Author Liaison for assistance.
Bdnf variant is associated with milder motor symptom severity in early-stage Parkinson's disease.
Parkinsonism & related disorders 08, 2018 | Pubmed ID: 29759928
Correction to: Lewy body-like alpha-synuclein inclusions trigger reactive microgliosis prior to nigral degeneration.
Journal of neuroinflammation May, 2018 | Pubmed ID: 29843738
Quality Over Quantity: Advantages of Using Alpha-Synuclein Preformed Fibril Triggered Synucleinopathy to Model Idiopathic Parkinson's Disease.
Frontiers in neuroscience , 2018 | Pubmed ID: 30233303
Michigan State University
Joseph R. Patterson1,
Nicole K. Polinski2,
Megan F. Duffy1,3,
Christopher J. Kemp1,
Kelvin C. Luk4,
Laura A. Volpicelli-Daley5,
Nicholas M. Kanaan1,
Caryl E. Sortwell1,3,6
1Department of Translational Science and Molecular Medicine, Michigan State University,
2, The Michael J. Fox Foundation for Parkinson's Research,
3Neuroscience Program, Michigan State University,
4Center for Neurodegenerative Disease Research, Department of Pathology and Laboratory Medicine, University of Pennsylvania Perelman School of Medicine,
5Center for Neurodegeneration and Experimental Therapeutics, University of Alabama at Birmingham,
6, Mercy Health Hauenstein Neuroscience Medical Center
Privacy
Gebruiksvoorwaarden
Beleid
Neem contact met ons op.
Aanbevelen aan bibliotheek
JoVE Nieuwsbrieven
JoVE Journal
Methoden Collecties
JoVE Encyclopedia of Experiments
Archiveren
JoVE Core
JoVE Science Education
JoVE Lab Manual
JoVE Quiz
JoVE Playlist
Auteurs
Bibliothecarissen
Toegang
Over JoVE
JoVE Sitemap
Auteursrecht © 2025 MyJoVE Corporation. Alle rechten voorbehouden